IRIS Accounts Production v23.4.0.336 09785389 Board of Directors 1.1.23 31.12.23 31.12.23 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097853892022-12-31097853892023-12-31097853892023-01-012023-12-31097853892021-12-31097853892022-01-012022-12-31097853892022-12-3109785389ns15:EnglandWales2023-01-012023-12-3109785389ns14:PoundSterling2023-01-012023-12-3109785389ns10:Director12023-01-012023-12-3109785389ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3109785389ns10:SmallEntities2023-01-012023-12-3109785389ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3109785389ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3109785389ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3109785389ns10:FullAccounts2023-01-012023-12-3109785389ns10:Director22023-01-012023-12-3109785389ns10:RegisteredOffice2023-01-012023-12-3109785389ns5:CurrentFinancialInstruments2023-12-3109785389ns5:CurrentFinancialInstruments2022-12-3109785389ns5:ShareCapital2023-12-3109785389ns5:ShareCapital2022-12-3109785389ns5:FurtherSpecificReserve3ComponentTotalEquity2023-12-3109785389ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-3109785389ns5:RetainedEarningsAccumulatedLosses2023-12-3109785389ns5:RetainedEarningsAccumulatedLosses2022-12-3109785389ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3109785389ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3109785389ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-31
REGISTERED NUMBER: 09785389 (England and Wales)
















Unaudited Financial Statements

for the Year Ended 31 December 2023

for

Trident Pharma Properties Limited

Trident Pharma Properties Limited (Registered number: 09785389)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Trident Pharma Properties Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: Dr K Swaminathan
Mrs U Swaminathan





REGISTERED OFFICE: 51 Shimbrooks
Great Leighs
Chelmsford
Essex
CM3 1SG





REGISTERED NUMBER: 09785389 (England and Wales)





ACCOUNTANTS: Roches
Chartered Accountants
1 Manor Court
6 Barnes Wallis Road
Segensworth
Fareham
Hampshire
PO15 5TH

Trident Pharma Properties Limited (Registered number: 09785389)

Balance Sheet
31 December 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Investment property 4 501,000 515,000

CURRENT ASSETS
Debtors 5 550 482
Cash in hand - 1
550 483
CREDITORS
Amounts falling due within one year 6 381,306 385,297
NET CURRENT LIABILITIES (380,756 ) (384,814 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

120,244

130,186

PROVISIONS FOR LIABILITIES 14,820 17,480
NET ASSETS 105,424 112,706

CAPITAL AND RESERVES
Called up share capital 2 1
Non-distributable reserves 7 80,296 89,624
Retained earnings 25,126 23,081
SHAREHOLDERS' FUNDS 105,424 112,706

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Trident Pharma Properties Limited (Registered number: 09785389)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 April 2024 and were signed on its behalf by:





Dr K Swaminathan - Director


Trident Pharma Properties Limited (Registered number: 09785389)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Trident Pharma Properties Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans to related parties.

Financial assets & financial liabilities are initially recognised at the transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. However, if the arrangement constitutes a financing transaction then it is measured at the present value of the future receipts discounted at a market rate of interest.

Financial assets & financial liabilities classified as receivable within one year are not amortised.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

4. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 January 2023 515,000
Revaluations (11,516 )
Impairments (2,484 )
At 31 December 2023 501,000
NET BOOK VALUE
At 31 December 2023 501,000
At 31 December 2022 515,000

Trident Pharma Properties Limited (Registered number: 09785389)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. INVESTMENT PROPERTY - continued

Fair value at 31 December 2023 is represented by:
£   
Valuation in 2020 47,105
Valuation in 2021 31,000
Valuation in 2022 29,000
Valuation in 2023 (14,000 )
Cost 407,895
501,000

The directors have assessed the fair value of the property based on the value of similar properties in the vicinity taking into account the condition of the property.

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 168 -
Other debtors 382 482
550 482

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Amounts owed to associates 375,969 380,924
Taxation and social security 2,588 1,965
Other creditors 2,749 2,408
381,306 385,297

7. RESERVES
Non-distributable
reserves
£   
At 1 January 2023 89,624
Fair value adjustment (9,328 )

At 31 December 2023 80,296